Phosphocreatine system

Creatine's reputation rests on a specific piece of cell biology: the phosphocreatine system. Understanding how it works helps you separate the solid evidence from the speculation that surrounds this supplement.

From creatine to energy reserve

When creatine enters a cell, an enzyme attaches a phosphate group to it, converting it into phosphocreatine. Phosphocreatine sits in the cell as a rapid-access energy reserve, ready to donate its phosphate back to ADP to regenerate ATP within seconds [1, 2]. Glucose and fat can also produce ATP, but those pathways take longer. Phosphocreatine is the sprint, not the marathon.

Verhoeven's analysis suggests the practical implication follows directly: more intracellular creatine means a larger phosphocreatine buffer, which means greater capacity for short, intense bursts of activity [1, 2]. Creatine is therefore examined for both muscle contraction and neuronal firing. The muscle application is intuitive. The brain angle is less obvious but follows similar logic: the brain consumes roughly 20% of your daily energy [2], so a buffer that helps cells reload ATP faster is plausible there too.

Where the mechanism meets direct evidence

Plausible mechanisms become more interesting when someone measures the thing directly. Researchers used ³¹P magnetic resonance spectroscopy, a method that tracks high-energy phosphates non-invasively in the brain, and found that a single high dose of creatine measurably raised brain phosphocreatine and ATP levels. Cognitive performance under sleep deprivation improved as well [3]. That is direct evidence the phosphocreatine buffer loads in human brain tissue, not a reasonable inference from biochemistry.

Two important caveats apply. The effect was observed under sleep deprivation, an energy-stress condition, not during normal wakefulness. The study also addresses the buffer mechanism, not a general claim that creatine sharpens everyday cognition. Those are separate questions requiring their own evidence.

Why mechanism alone isn't enough

The phosphocreatine system is well-established physiology. Verhoeven's analysis presents it as the mechanistic backbone of most creatine research [1, 2], and that framing is reasonable. A plausible, measurable mechanism is useful: it tells you why an effect might exist and where to look for it.

What it doesn't do is confirm that a clinical outcome occurs. A cell that can reload ATP faster in a lab dish, or even in a brain under an MRS scanner, may or may not translate into the specific outcome you care about: muscle strength, recovery, memory, or mood. Each of those claims needs its own controlled evidence in humans. Mechanism is the hypothesis; the trial is the test.

Keeping that distinction clear is the difference between understanding creatine and being oversold on it.

Where the evidence is contested

The mechanism itself is not seriously disputed. The contested territory is whether the phosphocreatine buffer, once established, produces meaningful clinical benefits beyond the well-replicated strength and power findings. For muscle performance, primary evidence supports the connection. For brain outcomes, the single direct-measurement study [3] is promising but specific to a sleep-deprivation context. Verhoeven's synthesis frames brain creatine loading as plausible and supported in principle [1, 2], but stops short of treating improved everyday cognition as a settled outcome. Readers should expect that distinction to remain unresolved until larger, more varied trials report.

References

1. Physionic — "Creatine Debunked: No Extra Muscle Gained" (video 02)
2. Physionic — "Creatine Expert uncovers why 5 grams isn't Enough!" (video 06)
3. Gordji-Nejad 2024, Sci Rep — creatine & sleep-dep cognition · PubMed 38418540